CNA Finance

About the Author CNA Finance

CNA Finance is a leading finance and investing website that offers content from contributors around the world. Focusing heavily on stock market commentary, market analysis, and investing tips; it's a great place to find articles about all things finance! Joshua’s likes to discuss where assets will move in the market, what reports may be coming out and what to expect, economic conditions and more.

Biotech Beat: Valeant Pharmaceuticals Intl Inc (VRX), Clovis Oncology Inc (CLVS), KaloBios Pharmaceuticals Inc (KBIO)

by Terry Chrisomalis Valeant Pharmaceuticals Intl Inc On November 18, 2015, Valeant Pharmaceuticals Intl Inc (NYSE:VRX) had received approval for two new indications of …

Biotech Beat: Anavex Life Sciences Corp (AVXL), Sophiris Bio Inc (SPHS) and KaloBios Pharmaceuticals Inc (KBIO)

By Terry Chrisomalis Anavex Life Sciences Corp On November 9, 2015 Anavex Life Sciences Corp. (NASDAQ:AVXL) reported positive phase 2a results for the …

Biotech Beat: RXi Pharmaceuticals Corp (RXII), Zafgen Inc (ZFGN), Five Prime Therapeutics Inc (FPRX)

RXi Pharmaceuticals Corp On October 15, 2015, RXi Pharmaceuticals Corp (NASDAQ:RXII) announced positive phase 2a results for its RXI-109 compound. The trial, known …

Biotech Beat: Sarepta Therapeutics Inc (SRPT), Esperion Therapeutics Inc (ESPR), Valeant Pharmaceuticals Intl Inc (VRX)

By Terry Chrisomalis Sarepta Therapeutics Inc On October 1, 2015 shares of Sarepta Therapeutics Inc (NASDAQ:SRPT) ended the day up approximately 22 % …

Biotech Beat: Arrowhead Research Corp (ARWR), Heron Therapeutics Inc (HRTX), Vertex Pharmaceuticals Incorporated (VRTX)

Arrowhead Research Corp On September 24, 2015 shares of Arrowhead Research Corp (NASDAQ:ARWR) were up as much as 20% after announcing positive phase …

Biotech Beat: RXi Pharmaceuticals Corp (RXII), ACADIA Pharmaceuticals Inc. (ACAD), Valeant Pharmaceuticals Intl Inc (VRX)

By Terry Chrisomalis RXi Pharmaceuticals Corp On August 31, 2015 RXi Pharmaceuticals Corp (NASDAQ:RXII) announced that the 30-day review period for its IND of RXI-109 …

Biotech Beat: Gilead Sciences, Inc. (GILD), Synergy Pharmaceuticals Inc (SGYP), Omeros Corporation (OMER), AVEO Pharmaceuticals, Inc. (AVEO)

I’ve been saying this all year. Ultimately, Gilead Sciences, Inc.

Biotech Beat: Synergy Pharmaceuticals Inc (SGYP), MannKind Corporation (MNKD), Ibio Inc (IBIO), Novavax, Inc. (NVAX)

Synergy Pharmaceuticals Inc (NASDAQ:SGYP) is going through rough times in the market at the moment after missing expectations with regard to their most …

Biotech Beat: Synergy Pharmaceuticals (SGYP), MannKind Corporation (MNKD), Gilead Sciences, Inc. (GILD)

Synergy Pharmaceuticals Synergy Pharmaceuticals Inc (NASDAQ:SGYP) had an incredible day in the market yesterday after announcing the results of it’s second of two …

Biotech Beat: XOMA Corp (XOMA), Synergy Pharmaceuticals Inc (SGYP), MannKind Corporation (MNKD), CIGNA Corporation (CI)

XOMA Corp Stock Starts To Recover XOMA Corp (NASDAQ:XOMA) had an incredibly rough day in the market yesterday. After announcing that a recent Phase 3 …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts